Ethical and Epistemic Considerations for the Use of Artificial Intelligence in Ultra-Rare Disease Clinical Trials
Artificial intelligence (AI) is often discussed as a means to improve the efficiency of clinical trial recruitment (Lu et al. 2024). Yet in the context of ultra-rare conditions, AI may play a more ...
Authors
- Kellie Owens (ORCID: https://orcid.org/0000-0002-2602-5762)
- Lisa Kearns (ORCID: https://orcid.org/0000-0003-0825-0234)
- Alison Bateman-House
Institutions
- New York University (US)
Publication Details
- Journal
- The American Journal of Bioethics
- Published
- 2026-08-03
- DOI
- https://doi.org/10.1080/15265161.2026.2690940
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00